Risk adopted allogeneic hematopoietic stem cell transplantation using a reduced intensity regimen for children with thalassemia major-Reference-Cited by-同舟云学术

Risk adopted allogeneic hematopoietic stem cell transplantation using a reduced intensity regimen for children with thalassemia major

Published:2013-02-19 Issue:8 Volume:60 Page:1345-1349
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Hussein Ayad Ahmed¹,Al-Zaben Abdulhadi¹,Ghatasheh Lubna¹,Natsheh Abeer¹,Hammada Tuka¹,Abdel-Rahman Fawzi¹,Abu-Jazar Husam¹,Sharma Shanta²,Najjar Rula³,Frangoul Haydar⁴

Affiliation:

1. Bone Marrow and Stem Cell Transplantation Program; King Hussein Cancer Center (KHCC); Amman; Jordan

2. Department of Cellular Therapy and Applied Genomics; King Hussein Cancer Center (KHCC); Amman; Jordan

3. Department of Pharmacy; King Hussein Cancer Center (KHCC); Amman; Jordan

4. Pediatric Stem Cell Transplant Program; Monroe Carell Jr. Children's Hospital at Vanderbilt; Nashville, TN

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Reference16 articles.

1. Hematopoietic cell transplantation for thalassemia and sickle cell disease: Past, present and future;Bhatia;Bone Marrow Transplant,2008

2. Bone marrow transplantation in patients with thalassemia;Lucarelli;N Engl J Med,1990

3. How I treat thalassemia;Rachmilewitz;Blood,2011

4. Thalassemia as a global health problem: Recent progress toward its control in the developing countries;Weatherall;Ann N Y Acad Sci,2010

5. Prospective grading of graft-versus-host disease after unrelated donor marrow transplantation: A grading algorithm versus blinded expert panel review;Weisdorf;Biol Blood Marrow Transplant,2003

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Conditioning Regimens in Patients with β-Thalassemia Who Underwent Hematopoietic Stem Cell Transplantation: A Scoping Review;Journal of Clinical Medicine;2022-02-09

2. Advancing the care of β-thalassaemia patients with novel therapies;BLOOD TRANSFUS-ITALY;2022

3. HSCT remains the only cure for patients with transfusion-dependent thalassemia until gene therapy strategies are proven to be safe;Bone Marrow Transplantation;2021-09-16

4. Hematopoietic stem cell transplantation for people with β-thalassaemia;Cochrane Database of Systematic Reviews;2021-04-21

5. Pretransplant myeloid and immune suppression, reduced toxicity conditioning with posttransplant cyclophosphamide: Initial outcomes of novel approach for matched unrelated donor hematopoietic stem cell transplant for hemoglobinopathies;Pediatric Blood & Cancer;2021-01-20